Results 201 to 210 of about 41,065 (312)

A Rare Case of Blastomycosis in a Psoriasis Patient Treated With Ustekinumab (Stelara)

Clinical Case Reports, Volume 13, Issue 10, October 2025.
ABSTRACT Psoriasis is a chronic inflammatory skin condition mediated by T‐helper 1 (Th1) and T‐helper 17 (Th17) cytokines, including interleukin (IL)‐12, IL‐23, IL‐17, and tumor necrosis factor alpha (TNF‐α). Ustekinumab, a human monoclonal antibody against the p40 subunit of IL‐12/23, has revolutionized treatment of moderate to severe psoriasis but ...
Fatima Ghaffar, Ahmed Hassan, Masab Ali, Hafiz Noman Ijaz, Sajjad Jameel, Monika Kumari, Muhammad Husnain Ahmad   +6 more
wiley   +1 more source

Screening for toxicity of azole fungicides in <i>Caenorhabditis elegans</i> identifies triflumizole as a potent reproductive and developmental toxicant. [PDF]

MicroPubl Biol
Hughes S, Koopmans C, van Duursen M.
europepmc   +1 more source

Template directed incorporation of nucleotide mixtures using azole- nucleobase analogs [PDF]

, 1997
Geoffrey C. Hoops
openalex   +1 more source

Oxidant‐Free Amidation of Aldehydes Enabled by Electrophotocatalysis

Chemistry – A European Journal, Volume 31, Issue 55, October 1, 2025.
An electrophotocatalytic method for C(sp2)–N bond formation via radical‐polar crossover (RPC)‐HAT catalysis is presented. The mild operating conditions enable functionalization of a wide range of compounds, with electricity as the sole oxidant. Abstract Electrophotocatalysis (EPC) is emerging as a powerful tool in organic synthesis, offering unique ...
Dimitris I. Ioannou, Elena Bombonato, Jiri Sanramat, Joost N. H. Reek, Timothy Noël   +4 more
wiley   +1 more source

Characterisation of Antifungal Resistance to Azoles in Colombian Isolates of Malassezia spp. [PDF]

Mycoses
Galvis-Marín JC, Celis-Ramírez AM, Tabares-Villa FA, Zuluaga-Vélez A, Sepúlveda-Arias JC.   +4 more
europepmc   +1 more source

Can we prevent azole resistance in fungi?

, 1995
David W. Denning
openalex   +1 more source

A Phase 2 study of CPX‐351 in combination with venetoclax in patients with newly diagnosed high‐risk acute myeloid leukemia

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Venetoclax has been combined with intensive chemotherapy regimens in the treatment of acute myeloid leukemia (AML). We aimed to investigate the safety and efficacy of venetoclax combined with full‐dose CPX‐351 (CPX + VEN) in newly diagnosed (ND) AML.
Wei‐Ying Jen, Jennifer Croden, Emmanuel Almanza‐Huante, Courtney DiNardo, Kelly Chien, Danielle Hammond, Wei Qiao, Yesid Alvarado, Lucia Masarova, Andres E. Quesada, Sherry Pierce, Alex Bataller, Guillermo Garcia‐Manero, Amin Alousi, Nicholas Short, Naval Daver, Farhad Ravandi, Hagop Kantarjian, Tapan M. Kadia   +18 more
wiley   +1 more source

Effects of Treatment with Azoles Are Overstated [PDF]

The American Journal of Medicine, 2017
Maribel Salas, T. Christopher Mast, Hetty Waskin, Neika Vendetti   +3 more
openaire   +3 more sources

EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

HemaSphere, Volume 9, Issue 10, October 2025.
Abstract Mantle cell lymphoma (MCL) is a relatively rare B‐cell lymphoma subtype, with a higher incidence among males and a median age of 70 years at diagnosis. MCL is characterized by clinically diverse behavior, from indolent disease to extremely aggressive, related to the presence of biological risk factors such as proliferation rate and TP53 ...
Mats Jerkeman, Igor Aurer, Elias Campo, Chan Y. Cheah, Jonathan Clark, Jeanette Doorduijn, Toby A. Eyre, Martin Fehr, Eva Giné, Maria Gomes da Silva, Pavel Klener, Marco Ladetto, Vincent Ribrag, Ofer Shpilberg, Jan Walewski, Martin Dreyling, the EHA Guidelines Committee and the European MCL Network   +16 more
wiley   +1 more source

Synergistic inhibition of pathogenic fungi by oleanolic acid combined with azoles. [PDF]

Microbiol Spectr
Chen T, Liu S, Yang F, He Z, Tang M, Ge L, Zhang H, Liu S, Zhu X, Peng M, Zhang H, Cheng W, Sun Y.   +12 more
europepmc   +1 more source